Showing results (491-500 of 616) with videos related to
Sort By:
Pageof 62
Cancer Research|December 1, 1991
A phase I clinical and pharmacokinetic trial of hepsulfamP M Ravdin, K A Havlin, M V Marshall, et al.Dermatitis : Contact, Atopic, Occupational, Drug|October 15, 2019
Patch Test Practice Patterns of Members of the American Contact Dermatitis SocietyLarissa G Rodriguez-Homs, James Taylor, Beiyu Liu, et al.ACS Omega|March 16, 2026
BMV and CCMV-Based Viral Nanoparticles for Delivery of N‑Desmethyl-Tamoxifen as Treatment of Triple-Negative Breast CancerElizabeth Loredo-García, Pierrick G J Fournier, M Mariana Herrera-Hernandez, et al.Journal of Neurosurgery. Spine|October 14, 2015
Biomechanics of a flexible sublaminar connector in long-segment thoracic fixationNestor G Rodriguez-Martinez, Sam Safavi-Abbasi, Luis Perez-Orribo, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
A phase I study of docetaxel and 5-fluorouracil in patients with advanced solid malignanciesT Petit, C Aylesworth, H Burris, et al.Revue Scientifique Et Technique (International Office of Epizootics)|March 24, 2017
Prevalence of honeybee viruses in different regions of China and ArgentinaG Ding, N Fondevila, M A Palacio, et al.Breast (Edinburgh, Scotland)|May 8, 2020
Accelerated partial breast irradiation with interstitial multicatheter brachytherapy after breast-conserving surgery for low-risk early breast cancerNieves G Rodriguez-Ibarria, Ma Beatriz Pinar, Laura García, et al.Blood|August 25, 2005
Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignanciesPatrick A Zweidler-McKay, Yiping He, Lanwei Xu, et al.Anti-Cancer Drugs|August 1, 1992
A phase I clinical and pharmacokinetic study of the topoisomerase I inhibitor topotecan (SK&F 104864) given as an intravenous bolus every 21 daysJ G Wall, H A Burris, D D Von Hoff, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 6, 2018
Plasma glycomics predict cardiovascular disease in patients with ART-controlled HIV infectionsDouglas M Oswald, Edward S Sim, Courtney Baker, et al.Pageof 62